CLINICAL_TRIALS
ClinicalTrials.gov record update
Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03044626
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:51.710727+00:00
- Published At
- 2021-01-13T00:00:00+00:00
- Record Updated At
- 2021-01-13
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Carcinoma\uff0cNon-Small-Cell Lung", "Metastatic Lung Cancer", "Nonsmall Cell Lung Cancer", "Lung Adenocarcinoma Metastatic", "Large Cell Lung Carcinoma Metastatic"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-01-13"- protocolSection.identificationModule.nctId
"NCT03044626"- protocolSection.identificationModule.officialTitle
"Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.